Brian S. Posner, Director of Dyne Therapeutics DYN, has filed 8 purchases and 3 sales on the open market. Over the past 12 months that comes to a net purchase of $130.2K. The latest trade was on 06/08.

BP

BP

Brian S. Posner

Director

Company

Dyne Therapeutics DYN

First filing

23/05/08

Trades

17 trades

Buys / sales

8 / 3

12-month net buying

$130.2K

Last trade

06/08

FollowShare

Trading activity

6 months1 year2 years5 yearsAll

Transactions

Company	Trade type	Traded	Filed	Shares	Price	Value	Holding change
Dyne TherapeuticsDYN	Open-market buy	06/08	06/09	2,000 sh	$16.94	$33,880	+8.9%
Dyne TherapeuticsDYN	Open-market buy	06/03	06/05	2,500 sh	$17.48	$43,700	+12.5%
Arch Capital GroupACGL	Open-market sale	06/03	06/04	3,000 sh	$19.66	$58,980	−100.0%
Dyne TherapeuticsDYN	Open-market buy	05/26	05/28	2,000 sh	$18.21	$36,420	+11.1%
Dyne TherapeuticsDYN	Open-market buy	05/20	05/22	2,500 sh	$17.12	$42,800	+16.1%
Arch Capital GroupACGL	Open-market sale	05/11	05/12	2,000 sh	$17.14	$34,280	−100.0%
Dyne TherapeuticsDYN	Open-market buy	03/30	04/01	2,000 sh	$17.08	$34,160	+14.8%
Dyne TherapeuticsDYN	Open-market buy	03/11	03/13	2,000 sh	$19.35	$38,700	+17.4%
Arch Capital GroupACGL	Open-market sale	03/11	03/12	3,000 sh	$17.12	$51,360	−60.0%
Dyne TherapeuticsDYN	Open-market buy	03/06	03/10	3,000 sh	$15.06	$45,180	+35.3%
Arch Capital GroupACGL	Open-market buy	25/08/01	25/08/04	1,000 sh	$17.34	$17,340	+25.0%